ATYR vs CB · rev $190.0K vs P/E 14, rev $59.40B
aTyr Pharma, Inc. (ATYR) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported ATYR revenue for 2025-12-31 was $190.0K. Net income was -$74.1M. Revenue was down 19.1% from 2024-12-31 to 2025-12-31. ATYR currently screens at market cap $471.7M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
ATYR currently screens at market cap $471.7M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the ATYR and CB stock pages for the full models.
Not investment advice.